相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas
Cuihua Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Karnofsky Performance Status and Lactate Dehydrogenase Predict the Benefit of Palliative Whole-Brain Irradiation in Patients With Advanced Intra- and Extracranial Metastases From Malignant Melanoma
Richard Partl et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Exploratory investigation of eight circulating plasma markers in brain tumor patients
Aysegul Ilhan-Mutlu et al.
NEUROSURGICAL REVIEW (2013)
Brain metastases: pathobiology and emerging targeted therapies
Matthias Preusser et al.
ACTA NEUROPATHOLOGICA (2012)
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls
Mikkel Noerholm et al.
BMC CANCER (2012)
Blood Alterations Preceding Clinical Manifestation of Glioblastoma
Ayseguel Ilhan-Mutlu et al.
CANCER INVESTIGATION (2012)
Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients
Ayseguel Ilhan-Mutlu et al.
CANCER INVESTIGATION (2012)
Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers
Anna Sophie Berghoff et al.
CLINICAL NEUROPATHOLOGY (2012)
G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker
Xiaoyi Zheng et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
Qiong Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Serum YKL-40 following resection for cerebral glioblastoma
Daniela Bernardi et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Decrease in circulating endothelial progenitor cells in treated glioma patients
Elena Corsini et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Association Between Prediagnostic IgE Levels and Risk of Glioma
Judith Schwartzbaum et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
The alteration of plasma TGF-β1 levels in patients with brain tumors after tumor removal
Joon-Khim Loh et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2012)
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Huilin Shao et al.
NATURE MEDICINE (2012)
S100B protein as a possible participant in the brain metastasis of NSCLC
Xiaowen Pang et al.
MEDICAL ONCOLOGY (2012)
Detection of IDH1 mutation in the plasma of patients with glioma
Blandine Boisselier et al.
NEUROLOGY (2012)
Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma
Jeffrey Allen et al.
PEDIATRIC BLOOD & CANCER (2012)
Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis
Poonam Gautam et al.
PLOS ONE (2012)
Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort
B. Schlehofer et al.
ALLERGY (2011)
YKL-40 and MMP-9 as Serum Markers for Patients with Primary Central Nervous System Lymphoma
Andreas F. Hottinger et al.
ANNALS OF NEUROLOGY (2011)
Plasma netrin-1 is a diagnostic biomarker of human cancers
Ganesan Ramesh et al.
BIOMARKERS (2011)
Neurospecific Proteins in the Serum of Patients with Brain Tumors
N. V. Lyubimova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Number of Metastases, Serum Lactate Dehydrogenase Level, and Type of Treatment Are Prognostic Factors in Patients With Brain Metastases of Malignant Melanoma
Thomas K. Eigentler et al.
CANCER (2011)
Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients
Carmen Balana et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Poor reliability and reproducibility of PCR-based testing of O6-methylguanine-DNA methyltransferase gene (MGMT) promoter methylation status in formalin-fixed and paraffin-embedded neurosurgical biopsy specimens
M. Preusser et al.
CLINICAL NEUROPATHOLOGY (2011)
IDH testing in diagnostic neuropathology: review and practical guideline article invited by the Euro-CNS research committee
M. Preusser et al.
CLINICAL NEUROPATHOLOGY (2011)
G-protein coupled receptor-associated sorting protein 1 (GASP-1), a potential biomarker in breast cancer
George P. Tuszynski et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?
Carsten Nieder et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2011)
Myxopapillary Ependymoma With Pleuropulmonary Metastases and High Plasma Glial Fibrillary Acidic Protein Levels
Ayseguel Ilhan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Identification of diagnostic serum protein profiles of glioblastoma patients
Anja Elstner et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide
Elizabeth R. Gerstner et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
Fabio M. Iwamoto et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
A specific miRNA signature in the peripheral blood of glioblastoma patients
Patrick Roth et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Value and Limitations of Immunohistochemistry and Gene Sequencing for Detection of the IDH1-R132H Mutation in Diffuse Glioma Biopsy Specimens
Matthias Preusser et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Allergies and Adult Gliomas: Cohort Results Strengthen Evidence for a Causal Association
Faith G. Davis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
Matthew Crocker et al.
NEURO-ONCOLOGY (2011)
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
Fabio M. Iwamoto et al.
NEURO-ONCOLOGY (2011)
Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
Helen M. Heneghan et al.
ANNALS OF SURGERY (2010)
Circulating microRNAs in plasma of patients with gastric cancers
M. Tsujiura et al.
BRITISH JOURNAL OF CANCER (2010)
Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
Peddagangannagari Sreekanthreddy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations
Leopold Sellner et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Therapy and prophylaxis of brain metastases
Yvonne Kienast et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Proteomic Identification of Haptoglobin α2 as a Glioblastoma Serum Biomarker: Implications in Cancer Cell Migration and Tumor Growth
Durairaj Mohan Kumar et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Elevated blood markers 1 year before manifestation of malignant glioma
Wolfgang Gartner et al.
NEURO-ONCOLOGY (2010)
Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
Iris Lavon et al.
NEURO-ONCOLOGY (2010)
Biomarkers for Serum Diagnosis of Infectious Diseases and Their Potential Application in Novel Sensor Platforms
Luiz R. Goulart et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2010)
Monoclonal antibody specific for IDH1 R132H mutation
David Capper et al.
ACTA NEUROPATHOLOGICA (2009)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
Early Diagnosis of Acute Kidney Injury: The Promise of Novel Biomarkers
Sachin S. Soni et al.
BLOOD PURIFICATION (2009)
Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis
Oscar Arrieta et al.
BMC CANCER (2009)
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma
Oezge Alper et al.
CANCER SCIENCE (2009)
CXCL13 and CXCL12 in Central Nervous System Lymphoma Patients
Lars Fischer et al.
CLINICAL CANCER RESEARCH (2009)
Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers
Elena Corsini et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia
G. Gerstner et al.
HAEMOPHILIA (2009)
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors
Alfredo Conti et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas
Yi Lin et al.
NEURO-ONCOLOGY (2009)
P16 PROMOTER METHYLATION IN THE SERUM AS A BASIS FOR THE MOLECULAR DIAGNOSIS OF GLIOMAS
Toshihiko Wakabayashi et al.
NEUROSURGERY (2009)
SURROGATE MARKERS PREDICT ANGIOGENIC POTENTIAL AND SURVIVAL IN PATIENTS WITH GLIOBLASTOMA MULTIFORME
Jeffrey P. Greenfield et al.
NEUROSURGERY (2009)
PBEF1/NAmPRTase/Visfatin - A potential malignant astrocytoma/glioblastoma serum marker with prognostic value
P. Sreekanth Reddy et al.
CANCER BIOLOGY & THERAPY (2008)
Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis
Sreekanth P. Reddy et al.
CLINICAL CANCER RESEARCH (2008)
Serum α2-HS glycoprotein predicts survival in patients with glioblastoma
Vladimir Petrik et al.
CLINICAL CHEMISTRY (2008)
Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer
Masahiro Uehara et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators
Galina Gabriely et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
A. D. Norden et al.
NEUROLOGY (2008)
Serum GFAP is a diagnostic marker for glioblastoma multiforme
C. S. Jung et al.
BRAIN (2007)
Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas
T. Brommeland et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology
Haishi Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Insulin-like growth factor binding protein 2 promotes glioma development and progression
Sarah M. Dunlap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1
Justine R. Smith et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors
Laura Todaro et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas
Adilia Hormigo et al.
CLINICAL CANCER RESEARCH (2006)
Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer
Yue Chen et al.
LUNG CANCER (2006)
Increased concentrations of transforming growth factor β1 and β2 in the plasma of patients with glioblastoma
Thomas Schneider et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma
Tadahiro Nozoe et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke
C Foerch et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational study
Sharon Einav et al.
CRITICAL CARE (2006)
S100β as a predictor of brain metastases -: Brain versus cerebrovascular damage
MA Vogelbaum et al.
CANCER (2005)
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
JA Chan et al.
CANCER RESEARCH (2005)
Cns germinoma with elevated serum human chorionic gonadotropin level: Clinical characteristics and treatment outcome
H Ogino et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Low-molecular weight caldesmon as a potential serum marker for glioma
PP Zheng et al.
CLINICAL CANCER RESEARCH (2005)
Cathepsin D is a potential serum marker for poor prognosis in glioma patients
ME Fukuda et al.
CANCER RESEARCH (2005)
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy
M Ryberg et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Elevation of plasma and cerebrospinal fluid osteopontin levels in patients with atypical teratoid/rhabdoid tumor
CL Kao et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Serum S-100B as an indicator of early postoperative deterioration after meningioma surgery
G Stranjalis et al.
CLINICAL CHEMISTRY (2005)
Alexander disease: putative mechanisms of an astrocytic encephalopathy
C Mignot et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor
A Iwasaki et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Glial fibrillary acidic protein injury and multiple trauma in serum after traumatic brain
LE Pelinka et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2004)
Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors
PP Zheng et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Serum s100β -: A noninvasive marker of blood-brain barrier function and brain lesions
AA Kanner et al.
CANCER (2003)
Increased levels of plasma tissue factor pathway inhibitor in patients with glioblastoma and intracerebral metastases
R Gerlach et al.
NEUROLOGICAL RESEARCH (2003)
Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma
JR Smith et al.
BLOOD (2003)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors
A Pagenstecher et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Brain metastases at the time of presentation of nonsmall cell lung cancer: a multi-centric AERIO* analysis of prognostic factors
W Jacot et al.
BRITISH JOURNAL OF CANCER (2001)
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
LF Eng et al.
NEUROCHEMICAL RESEARCH (2000)
分享论文
